Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05394181

Notify 2: An Evaluation of the Impact of Notification of Incidental Coronary Artery Calcium on Statin Rates

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The primary objective is to estimate the impact of notification of primary care provider and patient of at least moderate incidental coronary artery calcification (CAC) on a prior non-gated chest CT on statin prescription rates at 4 months among patients without a clinical history of atherosclerotic cardiovascular disease not actively on statin therapy. This study will determine if notifying patients and their primary care clinician about an existing finding will influence shared decision-making around statins between patients and their primary care clinician.

Conditions

Interventions

TypeNameDescription
OTHERNotificationNotification of patient and primary care clinician of presence of at least moderate coronary artery calcium on a prior non-gated chest CT

Timeline

Start date
2022-08-01
Primary completion
2023-01-15
Completion
2023-03-15
First posted
2022-05-27
Last updated
2026-02-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05394181. Inclusion in this directory is not an endorsement.